Teravir Tablet

Tablet
Rs.1270for 1 bottle(s) (30 tablets each)
1
Unfortunately, we don't have any more items in stock
Available in other variants
Report Error

Composition FOR Teravir 300mg Tablet

Tenofovir disoproxil fumarate(300mg)

food interaction for Teravir Tablet

alcohol interaction for Teravir Tablet

pregnancy interaction for Teravir Tablet

lactation interaction for Teravir Tablet

food
alcohol
pregnancy
lactation
Teravir Tablet may be taken with or without food, but it is better to take it at a fixed time.
None
CAUTION
It is not known whether it is safe to consume alcohol with Teravir Tablet. Please consult your doctor.
CONSULT YOUR DOCTOR
Teravir Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
SAFE IF PRESCRIBED
Teravir Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
SAFE IF PRESCRIBED

SALT INFORMATION FOR Teravir 300mg Tablet

Tenofovir disoproxil fumarate(300mg)

Teravir tablet uses

{med_name} is used in the treatment of chronic hepatitis B virus (HBV) infection and HIV infection.

How teravir tablet works

Teravir Tablet is an antiviral medication. It prevents the multiplication of virus in human cells. This stops the virus from producing new viruses and clears up your infection.

Common side effects of teravir tablet

Diarrhea, Nausea, Rash, Weakness, Vomiting, Fatigue, Abdominal pain, Increased transaminase level in blood, Decreased phosphate level in blood, Decreased potassium level in blood, Pancreatic inflammation, Muscle weakness, Increased creatinine level in blood, Acute renal failure, Softening of bones, Lactic acidosis, Fatty liver disease, Hepatitis (viral infection of liver), Angioedema (swelling of deeper layers of skin), Pain, Dizziness, Depression, Insomnia (difficulty in sleeping), Fever, Itching, Interstitial nephritis, Nephrogenic diabetes insipidus

SUBSTITUTES FOR Teravir Tablet

29 Substitutes
29 Substitutes
Sorted By
RelevancePrice
  • Tenvir Tablet
    (30 tablets in bottle)
    Cipla Ltd
    Rs. 43.43/Tablet
    Tablet
    Rs. 1540.22
    pay 3% more per Tablet
  • Ricovir 300mg Tablet
    (30 tablets in bottle)
    Mylan Pharmaceuticals Pvt Ltd - A Viatris Company
    Rs. 37.60/Tablet
    Tablet
    Rs. 1173
    save 11% more per Tablet
  • Tenof Tablet
    (10 tablets in strip)
    Hetero Drugs Ltd
    Rs. 47.20/Tablet
    Tablet
    Rs. 487.33
    pay 11% more per Tablet
  • Rivofonet Tablet
    (30 tablets in bottle)
    Emcure Pharmaceuticals Ltd
    Rs. 44.40/Tablet
    Tablet
    Rs. 1373.56
    pay 5% more per Tablet
  • Samhep-TDF 300mg Tablet
    (30 tablets in bottle)
    Samarth Life Sciences Pvt Ltd
    Rs. 55.17/Tablet
    Tablet
    Rs. 1760.30
    pay 30% more per Tablet

Expert advice FOR Teravir Tablet

  • You have been prescribed Tenofovir disoproxil fumarate for the treatment of chronic hepatitis B virus (HBV) infection.
  • In combination with other medicines, it is used for the treatment of HIV infections.
  • Take it with food, as this increases the absorption of the medicine into the body.
  • Tenofovir disoproxil fumarate may cause dizziness or sleepiness. Do not drive or do anything requiring concentration until you know how it affects you.
  • You may still develop infections or other illnesses associated with viral infection while taking this medication.
  • You can also pass on HIV or HBV to others. Don't share needles or personal items that can have blood or body fluids on them.
  • During treatment and for at least six months after stopping this medicine, regular blood tests are needed to monitor your liver function, level of hepatitis B virus and blood cells in your blood.

Frequently asked questions FOR Teravir 300mg Tablet

Tenofovir disoproxil fumarate

Q. Does Teravir Tablet prevent passing of HIV-1 and HBV to others?
In case of HIV-1 infection, Teravir Tablet may reduce the risk of passing the virus to others, but the chances of infecting others still persist. However, in case of HBV infection, Teravir Tablet has not proven to reduce risk of transferring the virus to others. Therefore, the patients of both HIV-1 infection and HBV infection should practice safe sex and should not share dirty needles.
Q. Is Teravir Tablet safe?
Teravir Tablet is safe if used in the dose and duration advised by your doctor. Take it exactly as directed and do not skip any dose. Follow your doctor's instructions carefully and let your doctor know if any of the side effects bother you.
Q. How should I take Teravir Tablet?
You should take Teravir Tablet in the dose and duration advised by your doctor. Teravir Tablet works best when taken with meals or just afterwards. However, taking it without food does not reduce its effectiveness. If you have any doubts, consult your doctor.
Show More
Q. For how long do I need to take Teravir Tablet for HBV infection?
Duration of treatment will depend on the severity of HBV infection. You will need to take periodic blood tests to keep a check on the viral load and number of T cells. Your doctor will then decide the duration of the medicine accordingly. In some cases, treatment is required life long.
Q. I vomited after taking Teravir Tablet. What should I do?
Take another tablet of Teravir Tablet if you vomit within 1 hour of taking it. If you vomit after more than an hour of taking Teravir Tablet, then you need not take another tablet. Consult your doctor if you have vomiting every time you take Teravir Tablet or if the vomiting persists for a longer duration.
Q. What should I do if I forget to take Teravir Tablet?
If you forget to take Teravir Tablet within 12 hours of the time you usually take it, you should take Teravir Tablet with food as soon as possible and resume the normal dosing schedule. If you miss a dose of Teravir Tablet by more than 12 hours and it is almost time for the next dose, you should not take the missed dose and simply resume the usual dosing schedule.

Content on this page was last updated on 23 August, 2024, by Dr. Varun Gupta (MD Pharmacology)